125 related articles for article (PubMed ID: 20614206)
1. CDC 25A gene 263C/T, -350C/T, and -51C/G polymorphisms in breast carcinoma.
Karagoz ID; Ozaslan M; Cengiz B; Kalender ME; Kilic IH; Oztuzcu S; Gogebakan B; Demiryurek AT
Tumour Biol; 2010 Dec; 31(6):597-604. PubMed ID: 20614206
[TBL] [Abstract][Full Text] [Related]
2. Expression of cdc25A and cdc25B phosphatase in breast carcinoma.
Ito Y; Yoshida H; Uruno T; Takamura Y; Miya A; Kuma K; Miyauchi A
Breast Cancer; 2004; 11(3):295-300. PubMed ID: 15550849
[TBL] [Abstract][Full Text] [Related]
3. CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell-cycle regulation.
Sadeghi H; Golalipour M; Yamchi A; Farazmandfar T; Shahbazi M
J Cell Biochem; 2019 Mar; 120(3):2919-2928. PubMed ID: 30443958
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
Wu W; Fan YH; Kemp BL; Walsh G; Mao L
Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
Broggini M; Buraggi G; Brenna A; Riva L; Codegoni AM; Torri V; Lissoni AA; Mangioni C; D'Incalci M
Anticancer Res; 2000; 20(6C):4835-40. PubMed ID: 11205229
[TBL] [Abstract][Full Text] [Related]
9. Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells.
Feng X; Wu Z; Wu Y; Hankey W; Prior TW; Li L; Ganju RK; Shen R; Zou X
Mol Cell Biol; 2011 Aug; 31(16):3457-71. PubMed ID: 21670150
[TBL] [Abstract][Full Text] [Related]
10. Role of the Cdc25A phosphatase in human breast cancer.
Cangi MG; Cukor B; Soung P; Signoretti S; Moreira G; Ranashinge M; Cady B; Pagano M; Loda M
J Clin Invest; 2000 Sep; 106(6):753-61. PubMed ID: 10995786
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CDC25A and CDC25B in head and neck cancers.
Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
[TBL] [Abstract][Full Text] [Related]
12. No association of hypoxia inducible factor-1α gene polymorphisms with breast cancer in North-West Indians.
Sharma S; Kapahi R; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR
Asian Pac J Cancer Prev; 2014; 15(22):9973-8. PubMed ID: 25520138
[TBL] [Abstract][Full Text] [Related]
13. Constitutive overexpression of CDC25A in primary human mammary epithelial cells results in both defective DNA damage response and chromosomal breaks at fragile sites.
Cangi MG; Piccinin S; Pecciarini L; Talarico A; Dal Cin E; Grassi S; Grizzo A; Maestro R; Doglioni C
Int J Cancer; 2008 Sep; 123(6):1466-71. PubMed ID: 18566993
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer.
Bonin S; Brunetti D; Benedetti E; Gorji N; Stanta G
Virchows Arch; 2006 May; 448(5):539-44. PubMed ID: 16440198
[TBL] [Abstract][Full Text] [Related]
15. 17beta-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways.
Ru Lee W; Chen CC; Liu S; Safe S
J Cell Biochem; 2006 Sep; 99(1):209-20. PubMed ID: 16598773
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.
Albert H; Santos S; Battaglia E; Brito M; Monteiro C; Bagrel D
Clin Chem Lab Med; 2011 Oct; 49(10):1707-14. PubMed ID: 21675940
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
[TBL] [Abstract][Full Text] [Related]
18. T Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Susceptibility to Invasive Breast Cancer.
Cheng S; Ju Y; Han F; Wang Y; Xu Y; Qu T; Lu Z
Ann Clin Lab Sci; 2017 Nov; 47(6):668-675. PubMed ID: 29263040
[TBL] [Abstract][Full Text] [Related]
19. In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.
Kiyokawa H; Ray D
Anticancer Agents Med Chem; 2008 Dec; 8(8):832-6. PubMed ID: 19075565
[TBL] [Abstract][Full Text] [Related]
20. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases.
Ferguson AM; White LS; Donovan PJ; Piwnica-Worms H
Mol Cell Biol; 2005 Apr; 25(7):2853-60. PubMed ID: 15767688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
